BDBM385717 US10287292, Compound 1.029::US11059825, Compound 1.029

SMILES Cc1cn2cccc2c(n1)N1CC[C@@H](C1)NC(=O)c1ccn(n1)-c1ccc(Cl)cc1

InChI Key InChIKey=LCTPEFRUZCCKJY-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 385717   

TargetAtypical chemokine receptor 3(Human)
Chemocentryx

US Patent
LigandPNGBDBM385717(US10287292, Compound 1.029 | US11059825, Compound ...)
Affinity DataIC50: 500nMAssay Description:In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/27/2020
Entry Details
Go to US Patent

TargetAtypical chemokine receptor 3(Human)
Chemocentryx

US Patent
LigandPNGBDBM385717(US10287292, Compound 1.029 | US11059825, Compound ...)
Affinity DataIC50: 500nMAssay Description:In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/2/2022
Entry Details
Go to US Patent